The evolving role of biomarkers for osteoarthritis

Therapeutic Advances in Musculoskeletal Disease

Volumn 6, Issue 4, 2014, Pages 144-153

  Ishijima, Muneaki ^a   Kaneko, Haruka ^a   Kaneko, Kazuo ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

biomarkers; CTX II; osteoarthritis

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COLLAGEN TYPE 2; CRYOPYRIN; FIBULIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OSTEOCALCIN; RESISTIN; TRANSCRIPTION FACTOR SOX5; TRANSCRIPTION FACTOR SOX6; TRANSCRIPTION FACTOR SOX9;

AGING; BODY MASS; BONE; CARDIOVASCULAR RISK; CARTILAGE; DISEASE COURSE; DISEASE SEVERITY; HUMAN; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OSTEOARTHRITIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PREVALENCE; PROTEIN EXPRESSION; PROTEOMICS; RADIOGRAPHY; REVIEW; SCORING SYSTEM; SYNOVITIS; SYNOVIUM;

EID: 84908570298     PISSN: 1759720X     EISSN: 17597218     Source Type: Journal    
DOI: 10.1177/1759720X14541175     Document Type: Review

References (59)

1. Adam O. (2003) Dietary fatty acids and immune reactions in synovial tissue. Eur J Med Res 8: 381–387.
2. Albig A. Neil J. Schiemann W. (2006) Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res 66: 2621–2629.
3. Attur M. Belitskaya-Levy I. Oh C. Krasnokutsky S. Greenberg J. Samuels J. et al. (2011) Increased interleukin-1beta gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. Arthritis Rheum 63: 1908–1917.
4. Attur M. Krasnokutsky-Samuels S. Samuels J. Abramson S. (2013) Prognostic biomarkers in osteoarthritis. Curr Opin Rheumatol 25: 136–144.
5. Ayral X. Pickering E. Woodworth T. Mackillop N. Dougados M. (2005) Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis – results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 13: 361–367.
6. Baker K. Grainger A. Niu J. Clancy M. Guermazi A. Crema M. et al. (2010) Relation of synovitis to knee pain using contrast-enhanced MRIs. Ann Rheum Dis 69: 1779–1783.
7. Baker K. Matthan N. Lichtenstein A. Niu J. Guermazi A. Roemer F. et al. (2012) Association of plasma N-6 and N-3 polyunsaturated fatty acids with synovitis in the knee: the Most Study. Osteoarthritis Cartilage 20: 382–387.
8. Balk E. Lichtenstein A. Chung M. Kupelnick B. Chew P. Lau J. (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189: 19–30.
9. Barter M. Bui C. Young D. (2012) Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs. Osteoarthritis Cartilage 20: 339–349.
10. Bay-Jensen A. Andersen T. Charni-Ben Tabassi N. Kristensen P. Kjaersgaard-Andersen P. Sandell L. et al. (2008) Biochemical markers of type II collagen breakdown and synthesis are positioned at specific sites in human osteoarthritic knee cartilage. Osteoarthritis Cartilage 16: 615–623.
11. Berry P. Jones S. Cicuttini F. Wluka A. Maciewicz R. (2011) Temporal relationship between serum adipokines, biomarkers of bone and cartilage turnover, and cartilage volume loss in a population with clinical knee osteoarthritis. Arthritis Rheum 63: 700–707.
12. Bingham C. 3rd Buckland-Wright J. Garnero P. Cohen S. Dougados M. Adami S. et al. (2006) Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 54: 3494–3507.
13. Calder P. (2006) N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83: 1505S-1519S.
14. Christgau S. Garnero P. Fledelius C. Moniz C. Ensig M. Gineyts E. et al. (2001) Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 29: 209–215.
15. Cleland L. Caughey G. James M. Proudman S. (2006) Reduction of cardiovascular risk factors with longterm fish oil treatment in early rheumatoid arthritis. J Rheumatol 33: 1973–1979.
16. Cleland L. James M. (2012) Osteoarthritis. Omega-3 fatty acids and synovitis in osteoarthritic knees. Nat Rev Rheumatol 8: 314–315.
17. Conrozier T. Balblanc J. Richette P. Mulleman D. Maillet B. Henrotin Y. et al. (2011) Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: an open-label observational prospective study. J Orthop Res 30: 679–685.
18. Davis C. Karl J. Granell R. Kirwan J. Fasham J. Johansen J. et al. (2007) Can biochemical markers serve as surrogates for imaging in knee osteoarthritis? Arthritis Rheum 56: 4038–4047.
19. de Boer T. van Spil W. Huisman A. Polak A. Bijlsma J. Lafeber F. et al. (2012) Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. Osteoarthritis Cartilage 20: 846–853.
20. Denoble A. Huffman K. Stabler T. Kelly S. Hershfield M. Mcdaniel G. et al. (2011) Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc Natl Acad Sci U S A 108: 2088–2093.
21. Dwyer J. Allayee H. Dwyer K. Fan J. Wu H. Mar R. et al. (2004) Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 350: 29–37.
22. Erhart-Hledik J. Favre J. Asay J. Smith R. Giori N. Mundermann A. et al. (2012) A relationship between mechanically-induced changes in serum cartilage oligomeric matrix protein (COMP) and changes in cartilage thickness after 5 years. Osteoarthritis Cartilage 20: 1309–1315.
23. Fernandez-Puente P. Mateos J. Fernandez-Costa C. Oreiro N. Fernandez-Lopez C. Ruiz-Romero C. et al. (2011) Identification of a panel of novel serum osteoarthritis biomarkers. J Proteome Res 10: 5095–5101.
24. Ferrucci L. Cherubini A. Bandinelli S. Bartali B. Corsi A. Lauretani F. et al. (2006) Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 91: 439–446.
25. Fukuda I. Ishihara T. Ohmachi S. Sakikawa I. Morita A. Ikeda M. et al. (2012) Potential plasma biomarkers for progression of knee osteoarthritis using glycoproteomic analysis coupled with a 2D-LC-MALDI system. Proteome Sci 10: 36.
26. Henrotin Y. Gharbi M. Mazzucchelli G. Dubuc J. de Pauw E. Deberg M. (2012) Fibulin 3 peptides Fib3–1 and Fib3–2 are potential biomarkers of osteoarthritis. Arthritis Rheum 64: 2260–2267.
27. Hoch J. Mattacola C. Medina Mckeon J. Howard J. Lattermann C. (2011) Serum cartilage oligomeric matrix protein (sCOMP) is elevated in patients with knee osteoarthritis: a systematic review and meta-analysis. Osteoarthritis Cartilage 19: 1396–1404.
28. Honsawek S. Chayanupatkul M. (2010) Correlation of plasma and synovial fluid adiponectin with knee osteoarthritis severity. Arch Med Res 41: 593–598.
29. Ishijima M. Watari T. Naito K. Kaneko H. Futami I. Yoshimura-Ishida K. et al. (2011) Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis. Arthritis Res Ther 13: R22.
30. Jordan K. Syddall H. Garnero P. Gineyts E. Dennison E. Sayer A. et al. (2006) Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men. Ann Rheum Dis 65: 871–877.
31. Jung M. Christgau S. Lukoschek M. Henriksen D. Richter W. (2004) Increased urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis. Pathobiology 71: 70–76.
32. Kaneko H. Ishijima M. Doi T. Futami I. Liu L. Sadatsuki R. et al. (2013) Reference intervals of serum hyaluronic acid corresponding to the radiographic severity of knee osteoarthritis in women. BMC Musculoskelet Disord 14: 34.
33. Karsdal M. Byrjalsen I. Bay-Jensen A. Henriksen K. Riis B. Christiansen C. (2010) Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis–the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (SCT) treatment and diurnal variation. BMC Musculoskelet Disord 11: 125.
34. Koskinen A. Juslin S. Nieminen R. Moilanen T. Vuolteenaho K. Moilanen E. (2011) Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Res Ther 13: R184.
35. Kraus V. Burnett B. Coindreau J. Cottrell S. Eyre D. Gendreau M. et al. (2011) Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage 19: 515–542.
36. Kraus V. Kepler T. Stabler T. Renner J. Jordan J. (2010 a) First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis. PloS ONE 5: e9739.
37. Kraus V. Nevitt M. Sandell L. (2010 b) Summary of the OA Biomarkers Workshop 2009 – biochemical biomarkers: biology, validation, and clinical studies. Osteoarthritis Cartilage 18: 742–745.
38. Liu L. Ishijima M. Futami I. Kaneko H. Kubota M. Kawasaki T. et al. (2010) Correlation between synovitis detected on enhanced-magnetic resonance imaging and a histological analysis with a patient-oriented outcome measure for Japanese patients with end-stage knee osteoarthritis receiving joint replacement surgery. Clin Rheumatol 29: 1185–1190.
39. Lories R. Luyten F. (2011) The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol 7: 43–49.
40. Mateos J. Lourido L. Fernandez-Puente P. Calamia V. Fernandez-Lopez C. Oreiro N. et al. (2012) Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF. J Proteomics 75: 2869–2878.
41. Muraki S. Akune T. Oka H. Ishimoto Y. Nagata K. Yoshida M. et al. (2012) Incidence and risk factors for radiographic knee osteoarthritis and knee pain in japanese men and women: a longitudinal population-based cohort study. Arthritis Rheum 64: 1447–1456.
42. Muraki S. Oka H. Akune T. Mabuchi A. En-Yo Y. Yoshida M. et al. (2009) Prevalence of radiographic knee osteoarthritis and its association with knee pain in the elderly of Japanese population-based cohorts: the ROAD study. Osteoarthritis Cartilage 17: 1137–1143.
43. Ning L. Ishijima M. Kaneko H. Kurihara H. Arikawa-Hirasawa E. Kubota M. et al. (2011) Correlations between both the expression levels of inflammatory mediators and growth factor in medial perimeniscal synovial tissue and the severity of medial knee osteoarthritis. Int Orthop 35: 831–838.
44. Reijman M. Hazes J. Bierma-Zeinstra S. Koes B. Christgau S. Christiansen C. et al. (2004) A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arthritis Rheum 50: 2471–2478.
45. Reynard L. Loughlin J. (2012) Genetics and epigenetics of osteoarthritis. Maturitas 71: 200–204.
46. Schaffler A. Ehling A. Neumann E. Herfarth H. Tarner I. Scholmerich J. et al. (2003) Adipocytokines in synovial fluid. JAMA 290: 1709–1710.
47. Sharif M. Kirwan J. Charni N. Sandell L. Whittles C. Garnero P. (2007) A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis – association with disease progression. Rheumatology (Oxford) 46: 938–943.
48. Shimura Y. Kurosawa H. Sugawara Y. Tsuchiya M. Sawa M. Kaneko H. et al. (2013) The factors associated with pain severity in patients with knee osteoarthritis vary according to the radiographic disease severity: a cross-sectional study. Osteoarthritis Cartilage 21: 1179-1184.
49. Sowers M. Karvonen-Gutierrez C. Yosef M. Jannausch M. Jiang Y. Garnero P. et al. (2009) Longitudinal changes of serum comp and urinary CTX-II predict X-ray defined knee osteoarthritis severity and stiffness in women. Osteoarthritis Cartilage 17: 1609–1614.
50. Tanishi N. Yamagiwa H. Hayami T. Mera H. Koga Y. Omori G. et al. (2009) Relationship between radiological knee osteoarthritis and biochemical markers of cartilage and bone degradation (Urine CTX-II and NTX-I): the Matsudai Knee Osteoarthritis Survey. J Bone Miner Metab 27: 605–612.
51. van Spil W. Drossaers-Bakker K. Lafeber F. (2013) Associations of CTX-II with biochemical markers of bone turnover raise questions on its tissue origin: data from CHECK, a cohort study of early osteoarthritis. Ann Rheum Dis 72: 29–36.
52. van Spil W. Jansen N. Bijlsma J. Reijman M. Degroot J. Welsing P. et al. (2012 a) Clusters within a wide spectrum of biochemical markers for osteoarthritis: data from check, a large cohort of individuals with very early symptomatic osteoarthritis. Osteoarthritis Cartilage 20: 745–754.
53. van Spil W. Welsing P. Kloppenburg M. Bierma-Zeinstra S. Bijlsma J. Mastbergen S. et al. (2012 b) Cross-sectional and predictive associations between plasma adipokines and radiographic signs of early-stage knee osteoarthritis: data from CHECK. Osteoarthritis Cartilage 20: 1278–1285.
54. Wakabayashi T. Matsumine A. Nakazora S. Hasegawa M. Iino T. Ota H. et al. (2010) Fibulin-3 negatively regulates chondrocyte differentiation. Biochem Biophys Res Commun 391: 1116–1121.
55. Wong M. Siegrist M. Cao X. (1999) Cyclic compression of articular cartilage explants is associated with progressive consolidation and altered expression pattern of extracellular matrix proteins. Matrix Biol 18: 391–399.
56. Yoshimura N. Muraki S. Oka H. Kawaguchi H. Nakamura K. Akune T. (2011) Association of knee osteoarthritis with the accumulation of metabolic risk factors such as overweight, hypertension, dyslipidemia, and impaired glucose tolerance in Japanese men and women: the ROAD study. J Rheumatol 38: 921–930.
57. Yoshimura N. Muraki S. Oka H. Tanaka S. Kawaguchi H. Nakamura K. et al. (2012) Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthritis Cartilage 20: 1217–1226.
58. Yusuf E. Nelissen R. Ioan-Facsinay A. Stojanovic-Susulic V. Degroot J. van Osch G. et al. (2010) Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann Rheum Dis 69: 761–765.
59. Zainal Z. Longman A. Hurst S. Duggan K. Caterson B. Hughes C. et al. (2009) Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis. Osteoarthritis Cartilage 17: 896–905.